Survival nomogram for lesion-free time in human papillomavirus-positive women

Authors

  • Mario Gutiérrez Machado Hospital Provincial Universitario Gineco-Obstétrico “Mariana Grajales”. Villa Clara. Universidad de Ciencias Médicas de Villa Clara. Villa Clara. https://orcid.org/0000-0003-2695-6660

Keywords:

Human papillomavirus; nomogram; survival; cervical lesions; time-dependent ROC curves

Abstract

Introduction: Human papillomavirus infection is the main causal factor in the genesis of cervical lesions.

Objective: To design and validate a nomogram to predict lesion-free survival in human papillomavirus-positive women.

Material and Methods: Prospective cohort study (January 2020–December 2024) of 78 human papillomavirus-positive women without initial lesion; 6-months follow-up; event; and histological diagnosis of cervical lesion. Kaplan–Meier was estimated, curves were compared with log-rank, and a multivariate Cox model was fitted. The model was internally validated by bootstrap (1,000 replicates) and K-fold cross-validation (K=5). A nomogram was constructed from the final model and its discriminatory capacity was evaluated using time-dependent ROC curves at 24 and 40 months.

Results: Of 78 women, 16 (20.5%) developed a lesion during follow-up. The independent variables in the final model were: postcoital bleeding (HR=14.99; 95%CI: 3.24–69.39), Chlamydia trachomatis infection (HR=10.13; 95%CI: 2.53–40.63), and genotype 16 (HR=3.65; 95%CI: 1.21–10.97). Model C-index (concordance): 0.849. The nomogram showed a time-dependent AUC = 0.82 (95%CI: 0.65–0.97) at 24 months and AUC = 0.87 (95%CI: 0.77–1.00) at 40 months (best performance at 40 months). Bootstrap internal validation corrected optimism, maintaining an adjusted C-index of ≈0.837.

Conclusions: The nomogram facilitates estimating individual risk of developing cervical lesions among HPV-positive women and shows better discriminatory capacity at 40 months than at 24 months, reinforcing its usefulness for long-term surveillance.

Downloads

Download data is not yet available.

Author Biography

Mario Gutiérrez Machado, Hospital Provincial Universitario Gineco-Obstétrico “Mariana Grajales”. Villa Clara. Universidad de Ciencias Médicas de Villa Clara. Villa Clara.

El autor declara no tener conflicto de intereses.

References

1. Silva S, Ayoub HH, Johnston C, Atun R, Abu-Raddad LJ. Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study. PLoS Med [Internet]. 2022;19(12):e1003938. Disponible en: https://doi.org/10.1371/journal.pmed.1003938

2. Letafati A, Marvi SS, Nikzad A, Soltani M. Assessing HPV awareness and Knowledge in Future Health Professionals: A Survey of Health Science Students in Iran. J Community Health [Internet]. 2025;1. Disponible en: http://doi.org/10.1007/s10900-025-01486-2

3. Arrossi S, Straw C, Sanchez Antelo V. Implementación de las directrices de la OMS para el cribado, diagnóstico y tratamiento del cáncer cervicouterino: conocimientos y percepciones de los profesionales de la salud de Argentina. BMC Cancer [Internet]. 2024; 24:996. Disponible en: https://doi.org/10.1186/s12885-024-12650-7

4. Mendoza-Hernández MA, Hernández-Fuentes GA, Sánchez-Ramírez CA, Rojas-Larios F, Guzmán-Esquivel J. Time‑dependent ROC curve analysis to determine the predictive capacity of seven clinical scales for mortality in patients with COVID‑19: Study of a hospital cohort with very high mortality. Biomed Rep [Internet]. 2024;20(6):100. Disponible en: https://doi.org/10.3892/br.2024.1788

5. Khan I, Harshithkumar R, More A, Mukherjee A. Virus del Papiloma Humano: Un Enigma Desentrañado sobre la Carga Universal de Neoplasas Malignas. Pathogens [Internet]. 2023; 12(4):564. Disponible en: https://doi.org/10.3390/pathogens12040564

6. Lu Y, Wu Q, Wang L. Chlamydia trachomatis aumenta la persistencia del VPH mediante inmunomodulación. BMC Infect [Internet]. 2024; 229. Disponible en: https://doi.org/10.1186/s12879-024-09094-6

7. Geisler WM, Koltun WD, Abdelsayed N, Burigo J, Mena L. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial. Clin Infect Dis [Internet]. 2012;55(1):82-8. Disponible en: https://doi.org/10.1093/cid/cis291

8. Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol [Internet]. 2021;11:631972. Disponible en: https://doi.org/10.3389/fcimb.2021.631972

9. Rodríguez Puga R. Actualización de la Declaración de Helsinki, avances en ética y protección de la investigación médica. Rev Cubana Med Milit [Internet]. 2025 [Citado 03/08/2025];54(1):e025076247. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/76247

10. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health [Internet]. 2020;8(2):e191-e203. Disponible en: http://doi.org/10.1016/S2214-109X(19)30482-6

11. Huang J, Deng Y, Boakye D, Tin MS, Lok V, Zhang L, et al. Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis. Gynecologic Oncology [Internet]. 2022; 164(1):e85-92. Disponible en: http://doi.org/10.1016/j.ygyno.2021.11.005

12. Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? . Microbiome [Internet]. 2016;4(1):58. Disponible en: http://doi.org/10.1186/s40168-016-0203-0

13. Lu Y, Wu Q, Wang L, Ji L. Chlamydia trachomatis enhances HPV persistence through immune modulation. BMC Infect Dis [Internet]. 2024 ;24(1):229. Disponible en: http://doi.org/10.1186/s12879-024-09094-6

14. Bhuvanendran Pillai A, Mun Wong C, Zainal Abidin N, Fazlinda Syed NS, Fathulzhafran Mohamed HM, Rasidah Abd Ghani S, et al. Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis. Iran J Public Health [Internet]. 2022;51(3):508-517. Disponible en: https://doi.org/10.18502/ijph.v51i3.8926

15. Chen L, Luo D, Xiao H, Zeng Z, Luo H, Gao S, et al. Mycoplasma genitalium protein of adhesion inhibits human urethral epithelial cells apoptosis via CypA/PI3K/AKT/mTOR-dependent autophagy. Front Microbiol [Internet]. 2025;16:1570659. Disponible en: http://doi.org/10.3389/fmicb.2025.1570659

16. Yu J, Zhou Y, Luo H, Su X, Gan T. Mycoplasma genitalium infection in the female reproductive system: Diseases and treatment. Front Microbiol [Internet]. 2023;14:1098276. Disponible en: https://doi.org/10.3389/fmicb.2023.1098276

17. Ili C, López J, Reyes ME, Viscarra T, Buchegger K, Zanella L, et al. Detección e integración del virus del papiloma humano de alto riesgo en lesiones pre-neoplásicas en mujeres del sur de Chile: un estudio transversal. Rev chil infectol [Internet]. 2024 [Citado 11/08/2025];41(1):27-35. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182024000100027&lng=es

18. Segui-Pérez C, de Jongh R, Jonkergouw RLW, Pelayo P, Balskus EP. Prevotella timonensis degrades the vaginal epithelial glycocalyx through high fucosidase and sialidase activities. mBio [Internet]. 2024;15(9):e0069124. Disponible en: http://doi.org/10.1128/mbio.00691-24

19. Noguera-Juliàn M, Rocafort M, Guillén Y, Rivera J, Casadellà M, Nowak P, et al. Gut Microbiota Linked to Sexual Preference and HIV Infection. EBioMedicine [Internet]. 2016;5:135-46. Disponible en: http://doi.org/10.1016/j.ebiom.2016.01.032

20. Zhang H, Ca, Xia Y. Asociación entre la infección por el virus del herpes humano y el carcinoma cervical: una revisión sistemática y un metaanálisis. Virol J [Internet]. 2023; 20: 288. Disponible en: http://doi.org/10.1186/s12985-023-02234-5

21. Chuqi L, Yongzhen G, Lulu W, Ruixia G, Dongmei L. Asociación entre el virus del herpes simple tipo 2 y las infecciones por el virus del papiloma humano de alto riesgo: un estudio poblacional de la Encuesta Nacional de Examen de Salud y Nutrición, 2009-2016. The Journal of Infectious Diseases [Internet].2025;231(4):e650-e658. Disponible en: http://doi.org/10.1093/infdis/jiaf033

22. Uruguay. Ministerio de Salud Pública. Dirección General de la Salud. Manual Nacional de Inmunizaciones 2024. 2ed. Montevideo: MSP; 2024 [Citado 11/08/2025]. Disponible en: https://www.paho.org/sites/default/files/2024-12/manual-nacional-inmunizaciones2024.pdf

23. Zeng W, Liang Y, Zhou J, Lin H, Huang L, He D, et al. Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City. J Obstet Gynaecol [Internet]. 2023;43(1):2186780. Disponible en: http://doi.org/10.1080/01443615.2023.2186780

24. Gupta A, Singh K, Fatima S, Ambreen S, Zimmermann S, Younis R, et al. Correction: Gupta et al. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease. Nutrients [Internet]. 2023;15(11):2429. Disponible en: http://doi.org/10.3390/nu15112429

25. Gutiérrez Machado M, Suárez González JA. El co-test con genotipificación del virus del papiloma humano en mujeres con citología negativa: una estrategia necesaria para la prevención del cáncer cervical. Rev cubana obstet ginecol [Internet]. 2025 [Citado 14/08/2025];51:e677. Disponible en: https://revginecobstetricia.sld.cu/index.php/gin/article/view/677

26. Yong L, Li L, Wu J. Evaluación de modelos de nomogramas para predecir la supervivencia en tumores del estroma gastrointestinal gástrico mediante análisis de la base de datos SEER. Sci Rep [Internet]. 2024; 14:11494. Disponible en: http://doi.org/10.1038/s41598-024-62353-z

Published

2026-11-16

How to Cite

1.
Gutiérrez Machado M. Survival nomogram for lesion-free time in human papillomavirus-positive women. Rev haban cienc méd [Internet]. 2026 Nov. 16 [cited 2026 Nov. 17];25:e6192. Available from: https://revhabanera.sld.cu/index.php/rhab/article/view/6192

Issue

Section

Surgical Sciences